FSD Pharma Inc.
NASDAQ:HUGE
Overview | Financials
| Company Name | FSD Pharma Inc. |
| Symbol | HUGE |
| Currency | USD |
| Price | 0.09 |
| Market Cap | 66,671 |
| Dividend Yield | 0% |
| 52-week-range | 0.087 - 109.193 |
| Industry | Drug Manufacturers—Specialty & Generic |
| Sector | Healthcare |
| CEO | Mr. Zeeshan Saeed |
| Website | https://www.fsdpharma.com |
An error occurred while fetching data.
About FSD Pharma Inc.
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD




